Le Min
Impact in
Papers in
- Oncology 19
- Cancer Immunotherapy and Biomarkers 17
- CAR-T cell therapy research 5
-
- Receptor Mechanisms and Signaling 7
- Co-authors
- F. Stephen Hodi (11 shared papers)Sara M. Tolaney (9 shared papers)Romualdo Barroso‐Sousa (5 shared papers)Ursula B. Kaiser (12 shared papers)Ian E. Krop (1 shared paper)William T. Barry (1 shared paper)Ana C. Garrido-Castro (1 shared paper)Anand Vaidya (3 shared papers)
- Journals
- Molecular Endocrinology (3 papers)Cancer Immunology Research (3 papers)Endocrinology (3 papers)Genes & Diseases (3 papers)Journal of Biological Chemistry (2 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Le Min
40 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Oncology 1.8k
- Neurology 518
- Endocrinology, Diabetes and Metabolism 463
- Reproductive Medicine 222
- Epidemiology 726
Countries citing papers authored by Le Min
This map shows the geographic impact of Le Min's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Le Min with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Le Min more than expected).
Fields of papers citing papers by Le Min
This network shows the impact of papers produced by Le Min. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Le Min. The network helps show where Le Min may publish in the future.
Co-authors
The 25 scholars most cited alongside Le Min, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens Hit paper breakdown → | 2017 | 768 |
| 2 | Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints Hit paper breakdown → | 2018 | 357 |
| 3 | 2014 | 215 | |
| 4 | 2010 | 140 | |
| 5 | 2017 | 114 | |
| 6 | 2013 | 89 | |
| 7 | 2018 | 89 | |
| 8 | 2018 | 84 | |
| 9 | 2013 | 82 | |
| 10 | 2000 | 56 | |
| 11 | 2002 | 53 | |
| 12 | 2011 | 50 | |
| 13 | 2019 | 49 | |
| 14 | 2017 | 43 | |
| 15 | 2013 | 34 | |
| 16 | 2016 | 34 | |
| 17 | 2003 | 33 | |
| 18 | 2014 | 32 | |
| 19 | 2000 | 29 | |
| 20 | 2015 | 29 |
About Le Min
Le Min is a scholar working on Oncology, Molecular Biology, Epidemiology, Endocrinology, Diabetes and Metabolism and Reproductive Medicine, having authored 42 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (17 papers), Hypothalamic control of reproductive hormones (8 papers), Receptor Mechanisms and Signaling (7 papers), Immunotherapy and Immune Responses (7 papers), Neuroendocrine Tumor Research Advances (7 papers), Neuropeptides and Animal Physiology (6 papers), CAR-T cell therapy research (5 papers) and Pancreatic function and diabetes (3 papers). The work is most often cited by research in Oncology (1.8k citations), Neurology (518 citations), Endocrinology, Diabetes and Metabolism (463 citations), Reproductive Medicine (222 citations) and Epidemiology (726 citations). Le Min has collaborated with scholars based in United States, China and Canada. Frequent co-authors include F. Stephen Hodi, Sara M. Tolaney, Romualdo Barroso‐Sousa, Ursula B. Kaiser, Ian E. Krop, William T. Barry, Ana C. Garrido-Castro, Anand Vaidya, Carolyn Black Becker and Lee‐Shing Chang. Their work appears in journals such as Molecular Endocrinology, Cancer Immunology Research, Endocrinology, Genes & Diseases and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.